BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17958343)

  • 1. Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues.
    Chen L; Gao G; Felczak K; Bonnac L; Patterson SE; Wilson D; Bennett EM; Jayaram HN; Hedstrom L; Pankiewicz KW
    J Med Chem; 2007 Nov; 50(23):5743-51. PubMed ID: 17958343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase.
    Rejman D; Olesiak M; Chen L; Patterson SE; Wilson D; Jayaram HN; Hedstrom L; Pankiewicz KW
    J Med Chem; 2006 Aug; 49(16):5018-22. PubMed ID: 16884314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a methylenebis(phosphonate) analogue of mycophenolic adenine dinucleotide: a glucuronidation-resistant MAD analogue of NAD.
    Lesiak K; Watanabe KA; Majumdar A; Powell J; Seidman M; Vanderveen K; Goldstein BM; Pankiewicz KW
    J Med Chem; 1998 Feb; 41(4):618-22. PubMed ID: 9484510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD-based inhibitors with anticancer potential.
    Felczak K; Vince R; Pankiewicz KW
    Bioorg Med Chem Lett; 2014 Jan; 24(1):332-6. PubMed ID: 24269162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.
    Pankiewicz KW; Lesiak-Watanabe KB; Watanabe KA; Patterson SE; Jayaram HN; Yalowitz JA; Miller MD; Seidman M; Majumdar A; Prehna G; Goldstein BM
    J Med Chem; 2002 Jan; 45(3):703-12. PubMed ID: 11806722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment.
    Chen L; Wilson D; Jayaram HN; Pankiewicz KW
    J Med Chem; 2007 Dec; 50(26):6685-91. PubMed ID: 18038969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.
    Felczak K; Chen L; Wilson D; Williams J; Vince R; Petrelli R; Jayaram HN; Kusumanchi P; Kumar M; Pankiewicz KW
    Bioorg Med Chem; 2011 Mar; 19(5):1594-605. PubMed ID: 21324702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase.
    Chen L; Petrelli R; Olesiak M; Wilson DJ; Labello NP; Pankiewicz KW
    Bioorg Med Chem; 2008 Aug; 16(15):7462-9. PubMed ID: 18583139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors.
    Franchetti P; Cappellacci L; Pasqualini M; Petrelli R; Jayaprakasan V; Jayaram HN; Boyd DB; Jain MD; Grifantini M
    Bioorg Med Chem; 2005 Mar; 13(6):2045-53. PubMed ID: 15727858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mycophenolic adenine bis(phosphonate)s as potential immunosuppressants.
    Pankiewicz KW; Lesiak-Watanabe K; Watanabe KA; Malinowski K
    Curr Med Chem; 1999 Jul; 6(7):629-34. PubMed ID: 10390605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues.
    Petrelli R; Sham YY; Chen L; Felczak K; Bennett E; Wilson D; Aldrich C; Yu JS; Cappellacci L; Franchetti P; Grifantini M; Mazzola F; Di Stefano M; Magni G; Pankiewicz KW
    Bioorg Med Chem; 2009 Aug; 17(15):5656-64. PubMed ID: 19596199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P; Grifantini M
    Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical consequences of resistance to tiazofurin in human myelogenous leukemic K562 cells.
    Jayaram HN; Zhen W; Gharehbaghi K
    Cancer Res; 1993 May; 53(10 Suppl):2344-8. PubMed ID: 8097964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside.
    Pankiewicz KW; Watanabe KA; Lesiak-Watanabe K; Goldstein BM; Jayaram HN
    Curr Med Chem; 2002 Apr; 9(7):733-41. PubMed ID: 11966436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of nonhydrolyzable analogues of thiazole-4-carboxamide and benzamide adenine dinucleotide containing fluorine atom at the C2' of adenine nucleoside: induction of K562 differentiation and inosine monophosphate dehydrogenase inhibitory activity.
    Lesiak K; Watanabe KA; Majumdar A; Seidman M; Vanderveen K; Goldstein BM; Pankiewicz KW
    J Med Chem; 1997 Aug; 40(16):2533-8. PubMed ID: 9258359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
    Carney DN; Ahluwalia GS; Jayaram HN; Cooney DA; Johns DG
    J Clin Invest; 1985 Jan; 75(1):175-82. PubMed ID: 2856924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD-analogues as potential anticancer agents: conformational restrictions as basis for selectivity.
    Pankiewicz KW; Zatorski A; Watanabe KA
    Acta Biochim Pol; 1996; 43(1):183-93. PubMed ID: 8790723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.
    Gharehbaghi K; Sreenath A; Hao Z; Paull KD; Szekeres T; Cooney DA; Krohn K; Jayaram HN
    Biochem Pharmacol; 1994 Oct; 48(7):1413-9. PubMed ID: 7945441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibitors of human inosine monophosphate dehydrogenase type II. Fluorine-substituted analogues of thiazole-4-carboxamide adenine dinucleotide.
    Zatorski A; Goldstein BM; Colby TD; Jones JP; Pankiewicz KW
    J Med Chem; 1995 Mar; 38(7):1098-105. PubMed ID: 7707313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel nicotinamide adenine dinucleotide analogues as potential anticancer agents: quest for specific inhibition of inosine monophosphate dehydrogenase.
    Pankiewicz KW
    Pharmacol Ther; 1997; 76(1-3):89-100. PubMed ID: 9535171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.